|
RU1819151C
|
|
Agent for treatment of late degenerative disease of nervous system
|
|
RU1807406C
|
|
Method for prognosticating predisposition to diabetic fetopathy
|
|
SU1755200A1
|
|
Method for diagnostics of chronic pancreatitis
|
|
SU1755201A1
|
|
Method for diagnosing chronic pancreatitis
|
|
RU1808333C
|
|
Method of oncoovarian acid-soluble alpha-2-globulin preparing
|
|
RU1827264C
|
|
Syringe-ampul
|
|
RU1803927C
|
|
Method of modelling acute myocardial ischemia
|
|
RU1814872C
|
|
Microelectrode
|
|
SU1803078A1
|
|
Method for prophylaxis of visual fatigue
|
|
RU1803875C
|
|
Method of anti-heparin activity of protamine preparation determination
|
|
RU1822981C
|
|
Method for diagnostics of chronic prostatitis
|
|
SU1736510A1
|
|
Method of treating post-trauma contractures of soft tissue structures
|
|
RU1805402C
|
|
Method for diagnosing course of myocardial infarction
|
|
RU1830283C
|
|
Way for modification of hemosorbents for purification of biological liquids
|
|
RU1774219C
|
|
Method of estimating degranulation of mast cells
|
|
SU1766362A1
|
|
Method for differential diagnostics of organic and functional troubles
|
|
RU1836957C
|
|
Method of trophoblastic beta-1-glycoprotein preparing
|
|
SU1767515A1
|
|
Method for simulating ventricle fibrillation
|
|
SU1743607A1
|
|
Method for prevention of intestinal dysbacteriosis in newborn infants
|
|
SU1727069A1
|
|
Method for determining indications to carry out remote crushing of concrements in the cases of cholelithic diseases
|
